Our Resources | Association for Accessible Medicines

GRx+Biosims - No-cost FDA workshop limited to first 100 who sign up. Act now!

Oct 16, 2019 | Rachel Schwartz

AAM Reaction to FDA Statement on Patient Access to Generic Drugs

California State Capitol - AB 824

Oct 8, 2019 | Rachel Schwartz

AAM Response to CA Governor Newsom Signing AB 824

Oct 3, 2019 | Jennifer Soup

GRx+Biosims Spotlight: The Exposition

Video

Oct 1, 2019 | Erica Klinger

35 Year Anniversary of Generic Medicines

Video

Sep 30, 2019 | Erica Klinger

Generic Medicines 35th Birthday Celebration

Sep 26, 2019 | Craig Burton

Three Recommendations to Save Money for Seniors and Taxpayers by Updating Medicare Part D

Sep 23, 2019 | Erica Klinger

Happy Birthday, Generic Prescription Drugs: 35 Years of Competition

Sep 20, 2019 | Craig Burton

White Paper: Access Denied: Why New Generics Are Not Reaching America's Seniors

Sep 20, 2019 | Rachel Schwartz

Seniors Denied Access to New, Lower-Priced Generic Drugs Due to Medicare Coverage Delays

Sep 18, 2019 | Erica Klinger

Report: 2019 Generic Drug & Biosimilars Access & Savings in the U.S.

White Paper: Biosimilars Council Failure to Launch Part 2

Sep 9, 2019 | Craig Burton

White Paper Part 2: Failure to Launch: Barriers to Biosimilar Market Adoption

Video

Sep 9, 2019 | Erica Klinger

AAM's Karin Hessler Provides an Inside Look at the GRx+Biosims 2019 Legal Track